Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanohydroxyapatite Paste for White Spot Lesions in Children
NCT06834464Completed
- Start
- Dec 2024
- Primary completion
- Jan 2025
- Modality
- Hydrogel Systems, Nanoparticles, Device-based Delivery
- Countries
- 1
01
Overview
Randomised, double-blind trial of nanohydroxyapatite in White spot lesion (WSL) (4 arms). Primary endpoint: Assessment of color change at 6 weeks. Started Dec 2024; status: completed.
02
Drugs
nanohydroxyapatite
03
Conditions
White spot lesion (WSL)
Beyond the preview
Go deeper on NCT06834464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06834464.